Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 326-337

  Gomella, Leonard G ^a   Raj, Ganesh V ^a   Moreno, Jose G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hematologic tests; Neoplasm metastasis; Polymerase chain reaction; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TREATMENT PLANNING;

EID: 0030752857     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64472-0     Document Type: Review

References (87)

1. Parker, S. L., Tong, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1997. CA, 74: 5, 1997.
2. Ablin, R. J., Bronson, P., Soanes, W. A. and Witelosky, E.: Tissue- and species-specific antigens of normal human prostatic tissue. J. Immunol., 104: 1329, 1970.
3. Wang, M. C., Papsidero, L. D., Kuriyama, M., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Prostate antigen: a new potential marker for prostate cancer. Prostate, 2: 89, 1981.
4. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159, 1979.
5. Watt, K. W. K., Lee, P. J., M'Timkulu, T., Chan, W. P. and Loor, R.: Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Nat. Acad. Sci., 88: 3166, 1986.
6. Monne, M., Croce, C. M., Yu, H. and Diamandis, E. P.: Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res., 54: 6344, 1994.
7. Yu, H., Diamandis, E. P. and Sutherland, D. J.: Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem., 27: 75, 1994.
8. Yu, H. and Diamandis, E. P.: Prostate-specific antigen in milk of lactating women. Clin. Chem., 41: 54, 1995.
9. Clements, J. and Mukhtar, A.: Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocr. Metab., 78: 1536, 1994.
10. Oesterling, J.: Molecular PSA: the next frontier in PCA screening. Contemp. Urol., 8: 76, 1996.
11. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
12. Gann, P. H., Hennekens, C. H. and Stampher, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. J.A.M.A., 273: 289, 1995.
13. Jacobs, S. C.: Spread of prostatic cancer to bone. Urology, 21: 337, 1983.
14. Batson, O. V.: The function of the vertebral veins and their role in the spread of metastases. Ann. Surg., 112: 138, 1940.
15. Warren, S., Harris, P. N. and Graves, R. C.: Osseous metastasis of carcinoma of the prostate with special reference to the perineural lymphatics. Arch. Path., 22: 139, 1936.
16. Whitmore, W. F., Jr.: Proceedings: the natural history of prostatic cancer. Cancer, 32: 1104, 1973.
17. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. and Gomella, L. G.: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110, 1992.
18. Fidler, I. J.: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A Clowes memorial award lecture. Cancer Res., 50: 6130, 1990.
19. Liotta, L. A., Kleinerman, J. and Saidel, G. M.: Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res., 34: 997, 1974.
20. Schirrmacher, V.: Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res., 43: 1, 1985.
21. Hamdy, F. C., Lawry, J., Anderson, J. B., Parsons, M. A., Rees, R. C. and Williams, J. L.: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Brit. J. Urol., 69: 392, 1992.
22. Baffa, R., Moreno, J. G., Monne, M., Veronese, L. and Gomella, L. G.: A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue. Urology, 47: 795, 1996.
23. Vessella, R. L., Riley, D. E., Blouke, K. A., Arfman, E. W. and Lange, P. H.: A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction. J. Urol., part 2, 147: 441A, abstract 914, 1992.
24. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.
25. Wood, D. P., Jr., Banks, E. R., Humphreys, S. and Rangnekar, V. M.: Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J. Histochem. Cytochem., 42: 505, 1994.
26. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F. and Rosai, J.: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195, 1995.
27. Ignatoff, J. M., Oefelein, M. G., Herz, B., Watkin, B. and Kaul, K. L.: Prostate specific antigen (PSA) reverse transcriptase-polymerase chain reaction (RT-PCR) assay in preoperative staging of prostate cancer. J. Urol., part 2, 155: 417A, abstract 427, 1996.
28. Layton, T. J., Melchior, S., Corey, E., Vessella, R. and Ross, A. A.: Comparative analysis of immunocytochemistry and RT-PCR for detection of bone marrow micrometastases in prostate cancer. Proc. Amer. Ass. Cancer Res., 37: 82, 1996.
29. Xuan, J. W., Chin, J. L., Guo, Y., Chambers, A. F., Finkelman, M. A. and Clarke, M. W.: Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene, 11: 1041, 1995.
30. Berthon, P., Dimitrov, T., Stower, M., Cussenot, O. and Maitland, N. J.: A microdissection approach to detect molecular markers during progression of prostate cancer. Brit. J. Cancer, 72: 946, 1995.
31. Gao, X., Gringon, D. J., Chbihi, T., Zacharek, A., Chen, Y. Q., Sakr, W., Porter, A. T., Crissman, J. D., Pontes, J. E., Powell, I. J., et al: Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology, 46: 227, 1995.
32. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J. and Heston, S.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
33. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Samadi, D. S., Powell, C. T., Heston, W. D. W., Wise, G. J. and Fair, W. R.: Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J. Urol., 153: 573, 1995.
34. Oakahashi, S., Shah, A. L., Ritland, S. R., Delacey, K. A., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N. and Jenkins, R. B.: Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55: 4114, 1995.
35. Hall, M. C., Navone, N. M., Troncoso, P., Pollack, A., Zagars, G. K., von Eschenbach, A. C., Conti, C. J. and Chung, L. W.: Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology, 45: 470, 1995.
36. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A. and Arnheim, N.: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230: 1350, 1985.
37. Eisenstein, B. I.: The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. New Engl. J. Med., 322: 182, 1990.
38. Arnheim, N. and Erlich, H.: Polymerase chain reaction strategy. Ann, Rev. Biochem., 61: 131, 1992.
39. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann. Biochem., 162: 156, 1987.
40. Vessella, R. L., Blouke, K. A., Stray, J. E., et al: The use of the polymerase chain reaction to detect metastatic prostate cancer in lymph nodes and bone marrow. Proc. Amer. Ass. Cancer Res., 33: 2367, 1992.
41. Wood, D. P., Jr.: The molecular staging of prostate cancer. Sem. Urol., 13: 96, 1995.
42. Moreno, J. G., Long, J. P., O'Hara, M., Veltri, R. W., Alexander, A., Shuppe-Byrne, D. and Gomella, L. G.: Surgical prostatic instrumentation causes showering of prostate cells into the circulation as determined by RT-PCR of PSA. J. Urol., part 2, 155: 553A, abstract 970, 1996.
43. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C. and Blair, G. E.: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338: 1227, 1991.
44. Naito, H., Kuzumaki, N., Uchino, J., Kobayashi, R., Shikano, T., Ishikawa, Y. and Matsumoto, S.: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer, 27: 762, 1991.
45. Miyamura, K., Tanimoto, M., Morishima, Y., Horibe, K., Yamamoto, K., Akatsuka, M., Kodera, Y., Kojima, S., Matsuyama, K., Hirabayashi, N., Yazaki, K., Imai, Y., Onozawa, A., Kanamauru, S., Mizutani, S. and Saito, H.: Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood, 79: 1366, 1992.
46. Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H. and Roth, M. S.: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12: 475, 1994.
47. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C. and Katz, A. E.: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373, 1995.
48. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G. and DeWolf, N.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
49. Jaakkola, S., Vornanen, T., Leinonen, J., Rannikko, S. and Stenman, U. H.: Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin. Chem., 41: 182, 1995.
50. Olsson, C. A., de Vries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K. M., Cao, Y., Buttyan, R. E. and Katz, A. E.: Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155: 1557, 1996.
51. Sokoloff, M. H., Tso, C. L., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., deKernion, J. and Belldegrun, A.: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinico-pathological molecular analysis of 121 patients. J. Urol., part 2, 156: 417A, abstract 1560, 1996.
52. Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Arfman, E. W., Oswin, M., Layton, T., Lange, P. H. and Vessella, R. L.: Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate (CAP). J. Urol., part 2, 155: 554A, abstract 972, 1996.
53. Ellis, W. J., Vessella, R. L., Corey, E., Arfman, E., Ostwin, M., Melchior, S. and Lange, P. H.: Use of a reverse transcriptase polymerase chain reaction (RT-PCR) to detect prostate cancer cells in the blood. J. Urol., part 2, 155: 378A, abstract 272, 1996.
54. de Vries, G. M., Olsson, C. A., Benson, M. C., Connor, J. P., Buttyan, R. and Katz, A. E.: Qualitative and quantitative RT-PCR for PSA: molecular staging of prostate cancer. J. Urol., part 2, 155: 417A, abstract 426, 1996.
55. Sokoloff, M., Patel, A., Tso, C.-L., deKernion, J. and Belldegrun, A.: Surgical manipulation does not result in hematogenous dissemination of prostate cancer [PC] cells. J. Urol., part 2, 155: 528A, abstract 869, 1996.
56. Oefelein, M. G., Herz, B., Ignatoff, J. M. and Kaul, K. L.: Longitudinal assessment by prostate specific antigen (PSA) reverse transcriptase-polymerase chain reaction (RT-PCR) of circulating prostate epithelial cells following radical retropubic prostatectomy (RRP). J. Urol., part 2, 155: 552A, abstract 967, 1996.
57. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.
58. Moreno, J. G., Long, J. P., O'Hara, M., Ning, X., Veltri, R. W., Alexander, A. and Gomella, L. G.: Mechanism of human prostate cancer dissemination may involve iatrogenic factors as determined by PSA RT-PCR. Proc. Amer. Ass. Cancer Res., 37: 85, 1996.
59. Wood, D. P., Jr., Weinstein, M., Humphreys, S. and Rangnekar, V. M.: Prognostic significance of circulating prostate cells. J. Urol., part 2, 155: 418A, abstract 429, 1996.
60. Dumas, F., Eschwege, P., Blanchet, P., Benoit, G., Jardin, A., Lacour, B. and Loric, S.: Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma using prostate specific membrane antigen (PSM)-based nested reverse transcription polymerase chain reaction assay. J. Urol., part 2, 155: 506A, abstract 780, 1996.
61. O'Hara, M., Ning, X., Veltri, R. W., Hedican, S. P., Partin, A. W., Subong, E. N. P. and Walsh, P. C.: Quantitative reverse transcriptase PCR for prostate specific antigen (Q-RT-PCR-PSA) detect basal PSA mRNA levels in peripheral blood from subjects without prostate cancer. Proc. Amer. Ass. Cancer Res., 37: 200, 1996.
62. O'Hara, S. M., Veltri, R. W., Skirpstunas, P., Hedican, S. P., Partin, A. W., Nelson, J. B., Subong, E. N. P. and Walsh, P. C.: Basal PSA mRNA levels detected by quantitative reverse transcriptase polymerase chain reaction (Q-RT-PCR-PSA) in blood from subjects without prostate cancer. J. Urol., part 2, 155: 418A, abstract 430, 1996.
63. Deguchi, T., Doi, T., Ehara, H., Ito, S., Takahashi, Y., Nishino, Y., Fujihiro, S., Kawamura, T., Komeda, H., Horie, H. M., et al: Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 53: 5350, 1993.
64. Takahashi, T., Hoshi, S., Orikasa, S., Kaneda, T., Mao, H., Suzuki, K., Saitoh, H., Yoshikawa, K., Ohkawa, A., Mizonobe, K., Funato, T. and Kimura, N.: Genetic diagnosis of pelvic lymph node metastasis in prostate cancer. J. Urol., part 2, 155: 378A, abstract 271, 1996.
65. Edelstein, R. A., Zietman, A. L., de las Morenas, A., Krane, R. J., Babayan, R. K., Traish, A. and Moreland, R. B.: Implications of prostatic micrometastases to the pelvic lymph nodes: first report of an archival tissue gene expression study. J. Urol., part 2, 155: 550A, abstract 958, 1996.
66. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994.
67. Wood, D. P., Jr., Humphreys, S. and Rangnekar, V. M.: Effect of hormonal therapy on circulating prostate cells. J. Urol., part 2, 155: 553A, abstract 969, 1996.
68. Moreno, J. G., Shenot, P. J., Shupp-Byrne, D. and Gomella, L. G.: Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen. Tech. Urol., 2: 54, 1996.
69. Katz, A. E., de Vries, G. M., Begg, M. D., Raffo, A. J., Cama, C., O'Toole, K., Buttyan, R., Benson, M. C. and Olsson, C. A.: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75: 1642, 1995.
70. Yuan, J. J. J., Coplen, D. E., Petros, J. A., Figenshau, R. S., Ratliff, T. L., Smith, D. S. and Catalona, W. J.: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J. Urol., part 2, 147: 810, 1992.
71. Hanks, G. E., Leibel, S. and Kramer, S.: The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J. Urol., 129: 309, 1983.
72. Harty, J. I., Blicblum, S. and Amin, M.: In vitro technique for isolating prostatic cells from blood. J. Surg. Res., 26: 411, 1979.
73. Pansadoro, V., Sternberg, C. N., DePaula, F., Florio, A., Giannarelli, D. and Arcangeli, G.: Transurethral resection of the prostate and metastatic prostate cancer. Cancer, 68: 1895, 1991.
74. Bretton, P. R., Melamed, M. R., Fair, W. R. and Cote, R. J.: Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate, 25: 108, 1994.
75. Cama, C. L., Olsson, C. A., Buttyan, R., Wise, G. J., de Vries, G. and Katz, A. E.: Molecular staging of prostate cancer III - effects of digital rectal examination, cystoscopy, and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J. Urol., part 2, 155: 553A, abstract 971, 1996.
76. Melchior, S., Corey, E., Ross, A., Layton, T., Arfman, E., Oswin, M., Lange, P. and Vessela, R.: Highly sensitized reverse transcriptase polymerase chain reaction (RT-PCR) assay for prostate specific antigen (PSA) messenger RNA detects early tumor spread in patients with clinically localized prostate cancer. Proc. Amer. Ass. Cancer Res., 37: 89, 1996.
77. Israeli, R. S., Powell, C. T., Fair, W. R. and Heston, W. D.: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227, 1993.
78. Lintula, S., Leinonen, J. and Stenman, U.-H.: Expression of prostate-specific membrane antigen mRNA in peripheral blood of prostate cancer patients and healthy donors. J. Urol., part 2, 155: 693A, abstract 1527, 1996.
79. Leek, J., Lench, N., Maraj, B., Bailey, A., Carr, I. M., Andersen, S., Cross, J., Whelan, P., MacLennan, K. A., Meredith, D. M., et al: Prostate-specific membrane antigen: evidence for the existence of a second related human gene. Brit. J. Cancer, 72: 583, 1995.
80. Henttu, P. and Vihko, P.: cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochem. Biophys. Res. Comm., 160: 903, 1989.
81. Henttu, P., Lukkarinen, O. and Vihko, P.: Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int. J. Cancer, 45: 654, 1990.
82. Bichi, R., Martinazzo, G., Gomella, L. G. and Moreno, J. G.: C-trak detection of RT-PCR PSA products in prostate cancer molecular staging. J. Urol., part 2, 155: 553A, abstract 968, 1996.
83. Slawin, K., O'Hara, S. M., Song, W., Gottenger, E., Wang, D., Veltri, R. W., Lebovitz, R. and Kattan, M.: Comparison of results obtained using different RT-PCR-PSA assay methods on a single set of clinical specimens. J. Urol., part 2, 155: 417A, abstract 425, 1996.
84. Smith, M. R., Biggar, S. and Hussain, M.: Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for the detection of micrometastases. Cancer Res., 55: 2640, 1995.
85. Su, S. L., Huang, I. P., Fair, W. R., Powell, C. T. and Heston, W. D.: Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441, 1995.
86. Schalken, J. A.: Molecular methods for predicting the metastatic potential of prostate cancer. Cancer Surv., 11: 43, 1991.
87. Ennis, R., Katz, A., de Vries, G., Hsu, I., Buttyan, R., Benson, M., Schiff, P. and Olsson, C.: Detection of circulating prostate cancer cells via reverse transcriptase-polymerase chain reaction (RT-PCR) in patients with clinically localized prostate cancer: independence from other pretreatment characteristics. Proc. Amer. Ass. Cancer Res., 14: A643, 1996.